Results 41 to 50 of about 3,568 (212)

ETHICAL APPROACH TO PHARMACOTHERAPY OF COMORBID STATES [PDF]

open access: yes, 2009
Ethics is an indispensable component of health care policy. Pharmacotherapy of comorbidity requires the use of a greater number of different drugs that have complex drug-drug interactions and drug-patient interactions which can cause various side-effects
Gordan Bošković   +2 more
core   +1 more source

Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan [PDF]

open access: yes, 2015
Background: SUN(^_^)D, the Strategic Use of New generation antidepressants for Depression, is an assessor-blinded, parallel-group, multicenter pragmatic mega-trial to examine the optimum treatment strategy for the first- and second-line treatments for ...
Akio Mantani   +17 more
core   +2 more sources

Efficacy of Different Combination Therapies for Mania in Bipolar Disorder: A Systematic Review and Meta‐Analysis

open access: yesBrain and Behavior, Volume 15, Issue 12, December 2025.
ABSTRACT Objective To systematically evaluate the efficacy and safety of different combination therapies in the treatment of mania in bipolar disorder, and to provide evidence‐based support for individualized clinical treatment. Methods PubMed, Web of Science, Cochrane Library, CNKI, VIP, and Wanfang databases were systematically searched from ...
Peiling Yao, Pingan Ni, Liqin Yin
wiley   +1 more source

PSYCHOPHARMOCOTHERAPY FOR PHOBIC AND OBSESSIVE-COMPULSIVE DISORDERS IN SCHIZOPHRENIA SPECTRUM STATES

open access: yesНеврология, нейропсихиатрия, психосоматика, 2009
The paper describes the results of psychopharmacotherapy for obsessive-phobic disorders (OPD) in the structure of schizophrenia spectrum states. It is shown that not only the clinicodynamic features of OPD, but also the course of a schizophrenic process ...
A. V. Pavlichenko, L. G. Kessel'man
doaj   +1 more source

DIFFERENTIAL DIAGNOSIS OF PSYCHOTROPIC SIDE EFFECTS AND SYMPTOMS AND SIGNS OF PSYCHIATRIC DISORDERS [PDF]

open access: yes, 2009
Diagnostic recognition and distinguishing of psychotropic side effects which are phenomenological Identical/similar to symptoms and/or signs of psychiatric disorders undergoing psychotropic treatment, is an integral element within the general diagnostic ...
Ante Silić   +4 more
core   +1 more source

Report: Workshop on maternal mental health, February 11–12, 2024, cosponsored by the American College of Obstetricians and Gynecologists

open access: yesPregnancy, Volume 1, Issue 6, November 2025.
Abstract The Society for Maternal‐Fetal Medicine 2024 President's Workshop on maternal mental health, cosponsored by the American College of Obstetricians and Gynecologists, will be comprehensively described in this article. Workshop leaders and speakers represented the fields of obstetrics and gynecology (OBGYN), maternal‐fetal medicine (MFM), complex
Society for Maternal‐Fetal Medicine (SMFM)   +7 more
wiley   +1 more source

Neuropsychiatric aspects of severe brain injuries

open access: yesНеврология, нейропсихиатрия, психосоматика, 2014
The state-of-the-art of Russian neuropsychiatry and priority developments in different psychopathological syndromes in severe brain injuries are assessed.
O. S. Zaitsev
doaj   +1 more source

Literature Review on Counseling Groups for Social Phobia [PDF]

open access: yes, 2012
The practice of group counseling for individuals with social phobia is increasing and various therapies have been applied to develop comprehensive treatments.
Davis, Martha A
core   +1 more source

Nocebo Hypothesis Cognitive Behavioral Therapy for Functional Neurological Symptom Disorder (Motor Type): A Pilot Randomized Controlled Trial

open access: yesMovement Disorders, Volume 40, Issue 7, Page 1331-1342, July 2025.
Abstract Background A previous case series showed that Nocebo Hypothesis Cognitive Behavioral Therapy (NH‐CBT) is a promising treatment for Functional Neurological Symptom Disorder (FNSD). Objectives To further evaluate the potential efficacy of NH‐CBT in participants with FNSD (motor type).
Matt Richardson   +2 more
wiley   +1 more source

Сравнительная характеристика терапевтического действия разных доз анксиолитика фабомотизола у больных с тревожными расстройствами

open access: yesСовременная терапия психических расстройств, 2018
В экспериментальных исследованиях установлено, что фармакологическое действие селективного анксиолитика фабомотизола, производного бензимидазола, реализуется на различных моделях тревожных состояний в широком диапазоне доз – от 0,5 до 10,0 мг/кг. Цель
Незнамов, Г. Г.   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy